European Commission (EC)

259 articles with European Commission (EC)

• Amsterdam Molecular Therapeutics (AMT) Announces European Commission (EC) Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP

  1/30/2012

• Optimer Pharmaceuticals, Inc. Release: The European Commission (EC) Grants Marketing Authorization for DIFICLIR(TM) (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections

  12/14/2011

• Researchers Design Steady-Handed Robot for Brain Surgery, European Commission (EC) Reveals

  11/29/2011

• European Commission (EC) Clears Pfizer Inc.'s Pneumococcal Vaccine for Use in Individuals Over Age 50

  10/27/2011

• Biogen Idec, Inc. (Massachusetts) and Elan Corporation PLC Release: European Commission (EC) Approves Inclusion of Anti-JC Virus Antibody Status as a PML Risk Factor in TYSABRI Labeling

  6/22/2011

• European Commission (EC) Approves XEPLION(R) from Janssen-Cilag International NV for Treatment of Schizophrenia

  3/9/2011

• European Commission (EC) Approves Self-Administration Label for Shire plc's FIRAZYR(R) (icatibant) for the Symptomatic Treatment of Acute Hereditary Angioedema Attack

  3/3/2011

• Are Patent Deals Slowing Cheaper Drugs? - European Commission (EC) Reveals

  1/18/2011

• Electroactive Gel, A New Matter For The Heart? - University College Cork Heading the European Commission (EC)'s Project Reveals

  12/15/2010

• Allon Therapeutics, Inc. Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Hodgkin Lymphoma by the European Commission (EC)

  10/15/2010

• Pluristem Therapeutics Placenta Derived Cells Chosen by European Commission (EC)’s Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients

  8/30/2010

• Boehringer Ingelheim Corporation Release: Major European Regulatory Milestone in Cardiovascular Protection for MICARDIS(R) (telmisartan): Now Approved by the European Commission (EC) to Reduce the Risk of Cardiovascular (CV) Morbidity in High CV Risk Pati

  11/30/2009

• Mologen AG: European Commission (EC) Grants EUR 3 Million to Develop DNA Vaccine for Humans

  12/19/2008

• Europeans Skeptical About Animal Cloning for Food Production, European Commission (EC) Poll

  10/10/2008

• Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Form of Alpha1-Antitrypsin (AAT) From the European Commission (EC)

  7/24/2008

• Wyeth Pharmaceuticals (Pennsylvania) and Progenics Pharmaceuticals, Inc. Receive Approval from European Commission (EC) for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients

  7/3/2008

• Amgen Release: Mimpara® (cinacalcet) Receives European Commission (EC) Approval for Extension of Marketing Authorisation in the European Union

  6/24/2008

• Merck Sharp & Dohme: ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission

  12/21/2007

• European Commission (EC) Launches New Program to Increase Links Between Research Organizations Throughout the World

  11/30/2007